Spectral AI (NASDAQ: MDAI) is scheduled to announce its third quarter earnings for fiscal year 2025 on November 11, 2025, following the market’s close. Analysts predict that the company will report a loss of $0.08 per share, with expected revenue of approximately $5.062 million for the quarter. Investors are encouraged to stay updated by checking the company’s earnings overview page, which includes details about the earnings call set for 5:00 PM ET on the same day.
In its previous earnings report on August 12, 2025, Spectral AI disclosed a loss of $0.10 per share, falling short of the consensus estimate of $0.07 by $0.03. The company recorded revenues of $5.07 million, slightly below the anticipated $5.44 million. Analysts forecast that Spectral AI will finish the current fiscal year with an earnings per share (EPS) of $0 and a projected EPS of $-1 for the next fiscal year.
Stock Performance and Market Outlook
On Friday, shares of MDAI opened at $1.94. The stock has a 50-day simple moving average of $2.17 and a 200-day simple moving average of $2.08. With a market capitalization of $53.58 million, the company has a price-to-earnings ratio of -2.81 and a beta value of 0.91. Over the past year, Spectral AI’s shares have fluctuated, reaching a 12-month low of $1.01 and a high of $3.25.
Several institutional investors have recently adjusted their stakes in Spectral AI. Notably, Jane Street Group LLC acquired a new position during the second quarter, valued at approximately $74,000. Similarly, Marshall Wace LLP and XTX Topco Ltd purchased new positions worth $104,000 and $123,000, respectively. Additionally, Geode Capital Management LLC increased its holdings by 21.8%, now owning 152,958 shares valued at approximately $379,000. Currently, institutional and hedge funds own 67.08% of the company’s stock.
Analyst Ratings and Future Projections
Recent reports from analysts shed light on the market sentiment surrounding Spectral AI. On October 31, 2025, Weiss Ratings reaffirmed a “sell (e+)” rating for the stock. Meanwhile, Wall Street Zen downgraded its rating from “hold” to “strong sell” on August 16, 2025. Among the analysts, one has assigned a “buy” rating while another has rated it as a “sell.” According to data compiled by MarketBeat, the overall consensus rating for Spectral AI remains a “hold,” with an average price target set at $3.50.
Spectral AI, Inc. is focused on advancing predictive medical diagnostics within the United States. The company aims to enhance treatment decisions in wound care and has specific applications for patients suffering from burns and diabetic foot ulcers. The upcoming earnings report will offer further insights into the company’s financial health and strategic direction moving forward.
